These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36073469)

  • 1. Criteria for the Evaluation of Italian Scientific Institutes for Research, Hospitalization and Healthcare (IRCCS): Comparison with European Standards and Certification Models.
    Lovisolo L; Paoli G; Luciani MN; Scillieri GS; Giacomini M
    Stud Health Technol Inform; 2022 Aug; 298():122-126. PubMed ID: 36073469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of OECI accreditation program to cancer institutes of the Alleanza Contro il Cancro Italian Network: a special project supported by the Italian Ministry of Health.
    Paradiso A; Belardelli F
    Tumori; 2015; 101 Suppl 1():S2-5. PubMed ID: 27096264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European accreditation of Istituto Tumori Giovanni Paolo II of Bari.
    Lacalamita R; Quaranta A; Trisorio Liuzzi MP; Nigro A; Simonetti U; Schirone M; Aloè F; Capochiani G; De Francesco G; Gadaleta C; Galetta D; Grammatica L; Guarini A; Mattioli V; Milella P; Moschetta A; Nardulli P; Nigro V; Silvestris N; Paradiso A
    Tumori; 2015; 101 Suppl 1():S14-8. PubMed ID: 27096266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experience of accreditation of the Reggio Emilia Research Hospital with the OECI model.
    Mazzini E; Cerullo L; Mazzi G; Costantini M
    Tumori; 2015; 101 Suppl 1():S42-6. PubMed ID: 27096272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.
    De Feo G; D'Ambrosio F; Palmieri G; Perrone F; Ciliberto G
    Tumori; 2015; 101 Suppl 1():S33-7. PubMed ID: 27096270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Comprehensive Cancer Care Network of Romagna: the opportunities generated by the OECI accreditation program.
    Ancarani V; Bernabini M; Zani C; Altini M; Amadori D
    Tumori; 2015; 101 Suppl 1():S55-9. PubMed ID: 27096275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).
    Saghatchian M; Hummel H; Otter R; de Valeriola D; Van Harten W; Paradiso A; Koot B; Ringborg U; Tursz T;
    Tumori; 2008; 94(2):164-71. PubMed ID: 18564602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OECI accreditation of the European Institute of Oncology of Milan: strengths and weaknesses.
    Deriu PL; Basso S; Mastrilli F; Orecchia R
    Tumori; 2015; 101 Suppl 1():S21-4. PubMed ID: 27096268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Historical-normative evolution of the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) in the landscape of Italian health].
    Passerino C; Zotta G
    G Ital Med Lav Ergon; 2008; 30(2):192-208. PubMed ID: 19068868
    [No Abstract]   [Full Text] [Related]  

  • 10. Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.
    Oberst S; Boomsma F; Lombardo C; Docter M; Blaauwgeers H; De Paoli P; de Valeriola D; Paradiso A; Saghatchian M
    Tumori; 2015; 101 Suppl 1():S6-9. PubMed ID: 27098181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OECI accreditation at Veneto Institute of Oncology IOV -- IRCCS, general framework and multidisciplinary approach.
    Chiusole D; Cioffredi P; Basso U; Bortolami A; Crivellari G; Gennaro G; Spina R; Opocher G
    Tumori; 2015; 101 Suppl 1():S38-41. PubMed ID: 27096271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The OECI certification/designation program: the Genoa experience.
    Orengo G; Pronzato P; Ferrarini M
    Tumori; 2015; 101 Suppl 1():S19-20. PubMed ID: 27096267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of European standards by CROB-IRCCS.
    Gallicchio R; Scapicchio D; Musto P; Storto G
    Tumori; 2015; 101 Suppl 1():S47-50. PubMed ID: 27096273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on: "Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES study." Escudier B, Porta C, Bono P, Powles T, Eisen T, Sternberg CN, Gschwend JE, De Giorgi U, Parikh O, Hawkins R, Sevin E, Négrier S, Khan S, Diaz J, Redhu S, Mehmud F, Cella D. Bernard Escudier, Institut Gustave Roussy, Villejuif; Emmanuel Sevin, Centre François Baclesse, Caen; Sylvie Négrier, Leon Berard Cancer Center, Lyon, France; Camillo Porta, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia; Cora N Sternberg, San Camillo Forlanini Hospital, Rome; Ugo De Giorgi, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; Petri Bono, Helsinki University Central Hospital, Helsinki, Finland; Thomas Powles, Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London; Tim Eisen, Cambridge University Health Partners, Cambridge; Omi Parikh, Royal Preston Hospital, Lancashire; Robert Hawkins, Christie Cancer Research UK, Manchester; Sadya Khan, Jose Diaz, and Faisal Mehmud, GlaxoSmithKline, Uxbridge, United Kingdom; Jürgen E Gschwend, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany; Suman Redhu, GlaxoSmithKline, Collegeville, PA; David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL.: J Clin Oncol. 2014 May 10;32(14):1412-1418; doi: 10.1200/JCO.2013.50.8267. [Epub 2014 Mar 31].
    Trump D
    Urol Oncol; 2016 May; 34(5):251. PubMed ID: 25937427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OECI model: the experience of INT Milan with a focus on the integration of psycho-oncology support.
    Roli A; Borreani C; Bosisio M; Bianchi E; Montefusco V; Gobbi G; Platania M; Lavecchia F; Milanesi M; Anselmi V; Melani C; De Leo G
    Tumori; 2015; 101 Suppl 1():S25-32. PubMed ID: 27096269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making patient centered care a reality: a survey of patient educational programs in Italian Cancer Research and Care Institutes.
    Cipolat Mis C; Truccolo I; Ravaioli V; Cocchi S; Gangeri L; Mosconi P; Drace C; Pomicino L; Paradiso A; De Paoli P;
    BMC Health Serv Res; 2015 Jul; 15():298. PubMed ID: 26223861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers.
    Deriu PL; La Pietra L; Pierotti M; Collazzo R; Paradiso A; Belardelli F; De Paoli P; Nigro A; Lacalamita R; Ferrarini M; Pelicci P; Pierotti M; Roli A; Ciliberto G; Scala S; Amadori A; Chiusole D; Musto P; Fusco V; Storto G; De Maria R; Canitano S; Apolone G; Ravelli M; Mazzini E; Amadori D; Bernabini M; Ancarani V; Lombardo C
    Tumori; 2013; 99(6):293e-8e. PubMed ID: 24503807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleanza Contro il Cancro: the accreditation system of the Excellence Network of Italian Cancer Centers in the precision medicine era.
    Palombo F; De Paoli P; De Maria R
    Tumori; 2015; 101 Suppl 1():S64-6. PubMed ID: 27096277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The OECI model: the CRO Aviano experience.
    Da Pieve L; Collazzo R; Masutti M; De Paoli P
    Tumori; 2015; 101 Suppl 1():S10-3. PubMed ID: 27096265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of accreditation for cancer patients: from end users to partners.
    Florindi F; De Lorenzo F
    Tumori; 2015; 101 Suppl 1():S60-3. PubMed ID: 27096276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.